| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Experimental Immunology and Transplantation, Division of Clinical Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702
The mechanisms by which cytotoxic agents perturb the normal cell biology and cell cycle progression of cancer cells were explored using B16F10 cells genetically modified to express the Herpes Simplex Virus-thymidine kinase gene. Culture in the presence of the nucleoside analogue ganciclovir induced a profound morphological change that required entry of treated cells into S phase and was dependent on prenylated proteins such as those of the rho gene family. Cell cycle arrest occurred in late S phase or G2 phase due to the activation of the G2-M DNA damage checkpoint. This checkpoint control operated at the level of inhibition of the activity of Cdc2/cyclin B and occurred by two mechanisms: (a) p53-mediated up-regulation of p21CIP1/WAF1 expression and its association with Cdc2/cyclin B; and (b) prevention of the dephosphorylation of tyrosine 15 of Cdc2. These events occurred in vitro and in vivo, and were shown to mediate bystander killing in this model. The mechanism of cell death seemed to be due to the irreversible cell cycle arrest at the G2-M checkpoint, rather than induction of apoptosis. These data link DNA damage checkpoints with cytoskeletal signaling pathways and the core cell cycle machinery and may represent a general mechanism of cytotoxicity of this class of nucleoside analogues.
1 To whom requests for reprints should be addressed, at Greenebaum Cancer Center, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201.
Received 3/20/98. Accepted 7/ 3/98.
This article has been cited by other articles:
|
|
 |
|
  W. Jalabi, N. Boehm, D. Grucker, and M. S. Ghandour Recovery of Myelin after Induction of Oligodendrocyte Cell Death in Postnatal Brain J. Neurosci., March 16, 2005; 25(11): 2885 - 2894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schuldiner, J. Itskovitz-Eldor, and N. Benvenisty Selective Ablation of Human Embryonic Stem Cells Expressing a "Suicide" Gene Stem Cells, May 1, 2003; 21(3): 257 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Mercer, C. E. Ahn, A. Coke, C. M. Compadre, and R. R. Drake Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies Protein Eng. Des. Sel., November 1, 2002; 15(11): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Adachi, J. Sampath, L.-b. Lan, D. Sun, P. Hargrove, R. Flatley, A. Tatum, M. Z. Edwards, M. Wezeman, L. Matherly, et al. Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing J. Biol. Chem., October 4, 2002; 277(41): 38998 - 39004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Thust, M. Tomicic, R. Klocking, P. Wutzler, and B. Kaina Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir Mutagenesis, March 1, 2000; 15(2): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Drake, T. N. Wilbert, T. A. Hinds, and K. M. Gilbert Differential Ganciclovir-mediated Cell Killing by Glutamine 125 Mutants of Herpes Simplex Virus Type 1 Thymidine Kinase J. Biol. Chem., December 24, 1999; 274(52): 37186 - 37192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beltinger, S. Fulda, T. Kammertoens, E. Meyer, W. Uckert, and K.-M. Debatin Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases PNAS, July 20, 1999; 96(15): 8699 - 8704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cortes-Bratti, C. Karlsson, T. Lagergard, M. Thelestam, and T. Frisan The Haemophilus ducreyi Cytolethal Distending Toxin Induces Cell Cycle Arrest and Apoptosis via the DNA Damage Checkpoint Pathways J. Biol. Chem., February 9, 2001; 276(7): 5296 - 5302. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
